Real-World Data on Prognostic Factors for Overall Survival in NSCLC Patients Treated with Bevacizumab Combination Therapy

被引：0
|
作者：
Wu, S. [1 ]
Liao, W. [1 ]
Ho, C. [1 ]
Shih, J. [1 ]
Yu, C. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Internal Med, Taipei, Taiwan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
bevacizumab; lung cancer; overall survival;
D O I：
10.1016/j.jtho.2018.08.966
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.15-33
引用
收藏
页码：S626 / S626
页数：1
相关论文
共 50 条
  • [1] Impact of Smoking on Survival in NSCLC Patients Treated with Chemoimmunoimmunotherapy or Chemotherapy: A Real-world Data Study
    Mostafa, A. A. Bani
    Al-Akhras, A.
    Tashtoush, S.
    Hamouri, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S420 - S421
  • [2] Overall Survival of Nonmetastasized NSCLC Patients Treated With Add-OnViscum albumL: A Multicenter Real-World Study
    Thronicke, Anja
    Matthes, Burkhard
    von Trott, Philipp
    Schad, Friedemann
    Grah, Christian
    [J]. INTEGRATIVE CANCER THERAPIES, 2020, 19
  • [3] Dynamic Prediction of Near-Term Overall Survival in Patients with Advanced NSCLC Based on Real-World Data
    Wang, Xuechen
    Kerrigan, Kathleen
    Puri, Sonam
    Shen, Jincheng
    Akerley, Wallace
    Haaland, Benjamin
    [J]. CANCERS, 2022, 14 (03)
  • [4] Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma
    Yu, Kenneth H.
    Ozer, Muhammet
    Cockrum, Paul
    Surinach, Andy
    Wang, Shu
    Chu, Bong Chul
    [J]. CANCER MEDICINE, 2021, 10 (24): : 8934 - 8943
  • [5] A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
    Jin, Shanmu
    Chen, Wenlin
    Guo, Xiaopeng
    Xing, Hao
    Yang, Huiyu
    Liu, Qianshu
    Liu, Delin
    Zhang, Kun
    Wang, Hai
    Xia, Yu
    Guo, Siying
    Wang, Yaning
    Shi, Yixin
    Li, Yilin
    Wang, Yuekun
    Li, Junlin
    Wu, Jiaming
    Liang, Tingyu
    Qu, Tian
    Li, Huanzhang
    Yang, Tianrui
    Wang, Yu
    Ma, Wenbin
    [J]. DISCOVER ONCOLOGY, 2024, 15 (01)
  • [6] A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
    Shanmu Jin
    Wenlin Chen
    Xiaopeng Guo
    Hao Xing
    Huiyu Yang
    Qianshu Liu
    Delin Liu
    Kun Zhang
    Hai Wang
    Yu Xia
    Siying Guo
    Yaning Wang
    Yixin Shi
    Yilin Li
    Yuekun Wang
    Junlin Li
    Jiaming Wu
    Tingyu Liang
    Tian Qu
    Huanzhang Li
    Tianrui Yang
    Yu Wang
    Wenbin Ma
    [J]. Discover Oncology, 15
  • [7] Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients
    Barlesi, F.
    Paz-Ares, L.
    Page, D.
    Shewade, A.
    Lambert, P.
    Mughal, T.
    Gay, L.
    Khorshid, M.
    Arnieri, B.
    Capra, W.
    Foser, S.
    Mascaux, C.
    Bubendorf, L.
    Wang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S459 - S460
  • [8] Development of a prognostic model of overall survival in oropharyngeal cancer from real-world data PROMETHEO
    Micciche, Francesco
    Chiloiro, Giuditta
    Longo, Silvia
    Autorino, Rosa
    Massaccesi, Mariangela
    Lenkowicz, Jacopo
    Bonomo, Pierluigi
    Desideri, Isacco
    Belgioia, Liliana
    Bacigalupo, Almalina
    D'Angelo, Elisa
    Bertolini, Federica
    Merlotti, Anna
    Denaro, Nerina
    Franco, Pierfrancesco
    Bussu, Francesco
    Paludetti, Gaetano
    Ricardi, Umberto
    Valentini, Vincenzo
    [J]. ACTA OTORHINOLARYNGOLOGICA ITALICA, 2022, 42 (03) : 205 - 214
  • [9] Anemia and Transfusion Dependency Are Important Prognostic Factors for Overall Survival in Patients with Myelofibrosis: Results of a Real-World Analysis of Medicare Patients
    Gerds, Aaron T.
    Mesa, Ruben A.
    Tkacz, Joseph
    Moore-Schiltz, Laura
    Schinkel, Jill
    Phiri, Kelesitse
    Liu, Tom
    Gorsh, Boris
    [J]. BLOOD, 2023, 142
  • [10] Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice
    Knetki-Wroblewska, Magdalena
    Dziadziuszko, Rafal
    Jankowski, Tomasz
    Krawczyk, Pawel
    Bryl, Maciej
    Stencel, Katarzyna
    Wrona, Anna
    Bandura, Artur
    Smok-Kalwat, Jolanta
    Rok-Knapinska, Jolanta
    Szydziak-Zwierzynska, Kinga
    Rogoziewicz, Krzysztof
    Czyzewicz, Grzegorz
    Wojtowicz, Monika
    Wojtukiewicz, Marek
    Kalinka, Ewa
    Wysocki, Piotr J.
    Lobacz, Mateusz
    Milanowski, Janusz
    Pawlik, Hubert
    Kowalski, Dariusz M.
    Krzakowski, Maciej
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
12345